The US AI research company Anthropic has become known for building powerful AI models while simultaneously warning about ...

While there have been many sober warnings about AI and recursive self-improvement, Arianna Huffington argues that it is a ...

Recursion Pharmaceuticals has been trying to rebuild momentum after a steep five year decline in shareholder returns, yet its ...

That admission is what some in the field call recursive self-improvement (RSI), the point at which large language models ...

It’s become a trope in Silicon Valley to liken the rise of AI to t. Hardcore AI true-believers often say that the rise of ...

These days, the frontier AI labs are all racing to build self-improving models. Some believe it’s the surest route to ...

These aren't for the faint of heart.

Recursion harnesses AI for large-scale drug discovery, while Summit's betting on a single oncology candidate. How do their ...

The founder of online bank Monzo has become the latest high-profile figure to join Anthropic, the AI company behind the Claude chatbot.

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the Best Penny Stocks to Invest In According to Billionaires.

Recursion and Exscientia, two pioneers in artificial intelligence (AI)-based drug development, have completed a business combination that they vowed will enhance their ability to carry out drug ...